Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBC.1.6.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBC.1.6.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GW.5.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GW.5.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GW.5.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GW.5.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KC.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KC.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KC.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KC.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.3.10ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.3.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.3.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.3.10NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FY.5.5.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FY.5.5.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.5.5.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.5.5.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.1.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.1.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FY.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FY.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.5.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.5.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.5.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.5.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FY.3.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FY.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.3.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.12ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.12NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FR.1.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FR.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FR.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FR.1.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.16.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.16.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.16.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.4.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.4.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.4.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.4.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used